Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis.

Author: AnseriniPaola, AreccoLuca, BonardiBenedetta, BruzzoneMarco, CeppiMarcello, Del MastroLucia, DemeestereIsabelle, GoldratOranite, LambertiniMatteo, MangiliGiorgia, MassarottiClaudia, SpinaciStefano

Paper Details 
Original Abstract of the Article :
<b>Background:</b> The co-administration of letrozole during controlled ovarian stimulation (COS) with gonadotropins is used to limit the potentially harmful effects of a supra-physiological rise in estrogen levels on hormone-sensitive cancers. However, the efficacy and safety of adding letrozole t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575927/

データ提供:米国国立医学図書館(NLM)

Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis

This systematic review and meta-analysis focuses on the use of [letrozole] in conjunction with [controlled ovarian stimulation (COS)] for [fertility preservation]. The researchers aim to assess the [efficacy and safety of letrozole co-administration] during COS, particularly for women with [hormone-sensitive cancers]. The study found that [letrozole co-administration did not negatively impact the efficacy of COS] and was associated with [significantly decreased peak estradiol levels].

Letrozole: A Safe and Effective Option for Fertility Preservation

This research provides reassuring data on the [use of letrozole in fertility preservation]. The study demonstrated that [letrozole co-administration did not negatively impact the number of mature oocytes retrieved] and [did not significantly affect other efficacy endpoints]. This suggests that [letrozole can be a safe and effective option] for [fertility preservation] in women with [hormone-sensitive cancers].

Balancing Fertility Preservation and Cancer Treatment

This research is significant for [women facing fertility challenges] due to [cancer treatment]. The study highlights the importance of [finding treatment options that balance fertility preservation with cancer treatment]. The findings suggest that [letrozole co-administration] may be a valuable tool for [minimizing the potential side effects] of [high estrogen levels] during [cancer treatment], while still allowing for [effective fertility preservation].

Dr.Camel's Conclusion

This research is a beacon of hope for women facing the difficult decision of balancing fertility preservation with cancer treatment. The findings suggest that letrozole can be a valuable tool for ensuring that women have the best possible chance of both overcoming cancer and preserving their fertility. This research is a testament to the ongoing efforts to improve the lives of women facing these challenging situations.

Date :
  1. Date Completed n.d.
  2. Date Revised 2020-10-30
Further Info :

Pubmed ID

33117711

DOI: Digital Object Identifier

PMC7575927

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.